SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence

Recruiting now · Not applicable

Conditions studied: Brain Tumors

In brief

This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to standardize care models and pathways for patients with rare brain tumors, using Artificial Intelligence (AI) and Machine Learning (ML) techniques to identify specific predictors of postoperative outcomes. The study includes both retrospective and prospective phases, with the collection of clinical, cognitive, and psychological data at various time points. Patients will undergo an early neuro-cognitive rehabilitation program using the RehaCom software, which will be conducted at home. The goal is to improve the quality of life and care for patients through a multidisciplinary and innovative approach.

Key facts

Study ID

NCT06878469

Run by

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

People needed

200

Starts

2025-01-27

Expected to finish

2027-02-01

Last updated by the study team

2026-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (age ≥18 years)
• Both sexes
• Patients with rare brain tumors (incidence <6 cases per 100,000 people/year)
• Candidates for craniotomy for rare brain tumors
• Native Italian speakers for cognitive and psychological evaluation and neuro-cognitive rehabilitation

You may not qualify if…

• Patients undergoing stereotactic/frameless biopsy
• Patients with psychiatric disorders or on psychotropic medications
• Patients with known cognitive decline (not due to the lesion)
• Patients admitted on the same day as the surgery
• Patients with severe impairments referred to rehabilitation centers
• Patients without a Windows PC or laptop with Internet connection for neuro-cognitive rehabilitation

Where it is running

• Fondazione IRCCS Istituto Neurologico Carlo Besta — Milan, PA, Italy (enrolling)
• ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila — L’Aquila, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.